Master in Biochemistry of the Pontificia Universidad Católica de Chile; Eduardo Neal-Silva Scholarship of the Wisconsin University (Madison, USA); Ph.D. in Biochemistry applied to bioclinic interfaces of the Université Pierre et Marie Curie (Paris, France). Extensive experience in biochemistry and molecular cell biology applied to the pathophysiology of atherosclerosis and lipid metabolism disorders both in basic research laboratories as in hospitals. Active participation in prospective and cross-sectional bioclinical trials in either HIV-infected or dyslipidemic patients at high risk of cardiovascular disease. Competences in lipoprotein and lipoprotein-associated metabolic networks characterization implied on their synthesis, remodeling and circulatory and intracellular degradation. Collaboration with ApoH-technologies SA. in set-up a ultra-sensitive diagnostic for emerging pathogens.